PICO Portalanswers from OpenAlex
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
PaperCitations, authors & open-access status
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial is a paper indexed in PICO Portal from OpenAlex.
How many citations does Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial have?
PICO Portalcitation count
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial has 794 citations in the OpenAlex counts PICO Portal stores.
When was Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial published?
PICO Portalyear
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial has 2020 year in the PICO Portal index.
What is the open-access status of Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial?
PICO Portaloa status
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial has green oa status in the PICO Portal index.
What is the DOI of Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial?
PICO Portaldoi
The DOI for Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial is on the source record.
What is the OpenAlex record for Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial?
PICO Portalopenalex
The OpenAlex for Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial is on the source record.